Search Within

David Scheinberg

Formats
  1. Journal Article (282)
  2. Meeting Abstract (193)
  3. Book Section (11)
  4. Conference Paper (7)
  5. Review (4)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Adult Leukemia (499)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (499)
  3. Center for Hematologic Malignancies (499)
  4. Department of Medicine (499)
  5. GSK Faculty (499)
  6. Hematologic Malignancies Research (499)

More Groups

People
  1. Michael Mcdevitt (117)
  2. Joseph Jurcic (84)
  3. Tao Dao (73)
  4. Peter Maslak (64)
  5. Steven Larson (63)
  6. Ronald Finn (52)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (12)
  4. 2022 (10)
  5. 2021 (11)
  6. 2020 (13)

More Years

Publications
  1. Blood (118)
  2. Journal of Nuclear Medicine (36)
  3. Journal of Clinical Oncology (21)
  4. Clinical Cancer Research (18)
  5. Leukemia (18)
  6. Cancer Research (16)

More Publications

Publishers
  1. American Society of Hematology (121)
  2. American Association for Cancer Research (54)
  3. Nature Publishing Group (43)
  4. Society of Nuclear Medicine (36)
  5. Elsevier Inc. (24)
  6. American Society of Clinical Oncology (21)

More Publishers

Results (499)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of targeted alpha-particle immunotherapy with actinium-225 ((225)Ac)-lintuzumab (Anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Levy, M. Y.; Estey, E. H.; Perl, A. E.; Kantarjian, H.; Earle, D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A therapeutic TCR mimic monoclonal antibody for intracellular PRAME protein in leukemias
    Meeting Abstract

    Chang, A.; Dao, T.; Scott, A.; Dubrovsky, L.; Liu, C.; Scheinberg, D. A.
    Blood (2015)

    Fulltext@MSK | Save
  • Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
    Journal Article

    Dao, T.; Pankov, D.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Xu, Y.; Xiang, J.; Yan, S. ; Direito de Morais Guerreiro, M.; Veomett, N.; more...
    Nature Biotechnology (2015)

    Fulltext@MSK | Save
  • PET-based compartmental modeling of (124)I-A33 antibody: Quantitative characterization of patient-specific tumor targeting in colorectal cancer
    Journal Article

    Zanzonico, P.; Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A. M.; Kemeny, N. E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save
  • Phase I trial of alpha-particle therapy with actinium-225 ((225)Ac)-lintuzumab (anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Levy, M. Y.; Estey, E.; Kantarjian, H. M.; Earle, D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Encapsulation of α-particle-emitting 225Ac3+ ions within carbon nanotubes
    Journal Article

    Matson, M. L.; Villa, C. H.; Ananta, J. S.; Law, J. J.; Scheinberg, D. A.; Wilson, L. J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Engineered T cell receptor-mimic antibody, (TCRm) chimeric antigen receptor (CAR) T cells against the intracellular protein Wilms tumor-1 (WT1) for treatment of hematologic and solid cancers
    Meeting Abstract

    Rafiq, S.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Phase I trial of targeted alpha-particle therapy using actinium-225 (Ac-225)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Wahl, R. L.; Earle, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Auxiliar treatment by targeting the extracellular matrix to improve drug delivery and therapeutic response
    Meeting Abstract

    Henke, E.; Roehrig, F.; Hoffmann, H.; Escorcia, F.; Wartenberg, M.; Volova, S.; Gaetzner, S.; Rosenwald, A.; Erguen, S.; Scheinberg, D. A.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save